Abstract
Activation of cannabinoid type-1 receptors (CB1) is universally recognized as a powerful endogenous orexigenic signal, but the detailed underlying neuronal mechanisms are not fully understood. Using combined genetic and pharmacological approaches in mice, we found that ventral striatal CB1 receptors exerted a hypophagic action through inhibition of GABAergic transmission. Conversely, brain CB1 receptors modulating excitatory transmission mediated the well-known orexigenic effects of cannabinoids.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Matias, I. & Di Marzo, V. Trends Endocrinol. Metab. 18, 27–37 (2007).
Piomelli, D. Nat. Rev. Neurosci. 4, 873–884 (2003).
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M. & Watanabe, M. Physiol. Rev. 89, 309–380 (2009).
Pagotto, U., Marsicano, G., Cota, D., Lutz, B. & Pasquali, R. Endocr. Rev. 27, 73–100 (2006).
Marsicano, G. & Kuner, R. in Cannabinoids and the Brain (ed. Kofalvi, A.) 161–201 (Springer, New York, 2008).
Kelley, A.E., Baldo, B.A., Pratt, W.E. & Will, M.J. Physiol. Behav. 86, 773–795 (2005).
Shin, A.C., Zheng, H. & Berthoud, H.R. Physiol. Behav. 97, 572–580 (2009).
Meena, H., Nakhate, K.T., Kokare, D.M. & Subhedar, N.K. Life Sci. 84, 156–163 (2009).
Wiley, J.L. et al. Br. J. Pharmacol. 145, 293–300 (2005).
Marsicano, G. et al. Nature 418, 530–534 (2002).
Monory, K. et al. Neuron 51, 455–466 (2006).
Monory, K. et al. PLoS Biol. 5, e269 (2007).
Goebbels, S. et al. Genesis 44, 611–621 (2006).
Yee, C.L., Wang, Y., Anderson, S., Ekker, M. & Rubenstein, J.L. J. Comp. Neurol. 517, 37–50 (2009).
Hudson, B.D., Hebert, T.E. & Kelly, M.E. Mol. Pharmacol. 77, 1–9 (2010).
Acknowledgements
We thank F. George, P. Ciofi, V. Deroche-Gamonet and O. Moustie for help, D. Gonzales and the Genotyping Platform of the NeuroCentre Magendie for mouse genotyping, S.K. Nave, J. Rubenstein, M. Ekker, G. Schütz, T. Lemberger for providing Cre-expressing mice, and C.T. Wotjak, U. Pagotto, K. Monory, J. Lourenço, M. Vallée, B. Lutz and all the members of the Marsicano laboratory for valuable suggestions. This work was supported by AVENIR/INSERM and Fondation Bettencourt-Schueller (G.M.), Agence National de la Recherche (ANR-06-NEURO-043-01 to G.M.), the European Foundation for the Study of Diabetes (G.M.), European Union Seventh Framework Program (REPROBESITY, HEALTH-F2-2008-223713 to G.M.), European Commission Network of European Neuroscience Institutes (ENINET) (LSHM-CT-2005-19063 to G.M.), the Basque Country Government (GIC07/70-IT-432-07 to P.G.), Red de Trastornos Adictivos, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Gobierno de España (RD07/0001/2001 to P.G.) and Basque Country University (N.P.).
Author information
Authors and Affiliations
Contributions
L.B. designed and performed experiments. P.L. carried out part of the food-intake experiments. A.C., N.P. and P.G. performed the anatomical experiments. D.C., F.C. and P.V.P. contributed to experimental design. P.V.P. and G.M. wrote the manuscript. All the authors edited the manuscript. G.M. conceived and supervised the project.
Corresponding author
Ethics declarations
Competing interests
The authors have filed a patent application (European Patent Office, “Compositions targeting CB1 receptor for controlling food intake”, EP09306163.8) that is based, in part, on the results of this study.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–14 and Supplementary Methods (PDF 2038 kb)
Rights and permissions
About this article
Cite this article
Bellocchio, L., Lafenêtre, P., Cannich, A. et al. Bimodal control of stimulated food intake by the endocannabinoid system. Nat Neurosci 13, 281–283 (2010). https://doi.org/10.1038/nn.2494
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.2494
This article is cited by
-
Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43
Nature Communications (2023)
-
Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials
Nature Medicine (2023)
-
Metabolic Messengers: endocannabinoids
Nature Metabolism (2022)
-
Cell type specific cannabinoid CB1 receptor distribution across the human and non-human primate cortex
Scientific Reports (2022)
-
Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons drives overconsumption of palatable food and obesity
Neuropsychopharmacology (2021)